Columbia University
Clinical trials sponsored by Columbia University, explained in plain language.
-
New drug combo aims to make stem cell transplants safer for sickle cell patients
Disease control TerminatedThis study tested whether adding the drug siplizumab to a stem cell transplant could prevent graft failure and graft-versus-host disease in people with advanced sickle cell disease. Only one person enrolled before the study was stopped early. The goal was to make transplants safe…
Phase: PHASE1, PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New study aims to protect new Moms' brains after severe preeclampsia
Disease control TerminatedThis early-stage study tested a new way to manage blood pressure in women who had severe preeclampsia after childbirth. It involved 26 participants, some of whom received standard care while others had personalized blood pressure targets based on real-time brain monitoring. The g…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Statin brain protection study halted early – results inconclusive
Disease control TerminatedThis study looked at whether giving high doses of statins for two weeks before carotid artery surgery could prevent brain damage and improve thinking. It included 31 adults with severe carotid artery narrowing. The study was stopped early, so the findings are not strong enough to…
Phase: PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New tracer aims to catch COPD damage early
Diagnosis TerminatedThis study tested whether a radioactive tracer called Annexin can detect early lung damage in people with COPD and in smokers. It included healthy non-smokers, healthy smokers, and patients with moderate to severe COPD. Participants had a CT scan, lung function tests, and a blood…
Phase: PHASE2 • Sponsor: Columbia University • Aim: Diagnosis
Last updated May 11, 2026 20:48 UTC
-
App aims to ease cancer treatment for minority patients
Symptom relief TerminatedThis study tested a mobile app called ApricityCare to help ethnic and racial minority patients with non-small cell lung cancer report side effects from immunotherapy. The goal was to reduce treatment delays and hospital visits. The study was terminated early, so results are limit…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
Suicide prevention study halted after enrolling only 7 patients
Knowledge-focused TerminatedThis study aimed to create a program to help suicidal patients stay in mental health treatment. Researchers planned to interview patients and staff, then test a new approach involving shared decision-making, phone outreach, and peer support. However, the study was terminated earl…
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Insulin's hidden role in psoriasis revealed?
Knowledge-focused TerminatedThis study aimed to understand if insulin works differently in psoriasis skin patches compared to healthy skin. Researchers took small skin samples from 10 people with plaque psoriasis before and after a sugar drink. The study was stopped early, so results are limited.
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC